Kewaunee Scientific Corporation (NASDAQ:KEQU) delivered a robust finish to its fiscal year, posting fourth-quarter results that far outpaced the prior year and sparked a 23.5% surge in after-hours trading.
For the quarter ending April 30, 2025, the laboratory equipment and furniture manufacturer reported adjusted earnings per share of $1.95, while revenue climbed 36.1% year-over-year to $77.15 million.
The standout performance was fueled by a 54.7% jump in U.S. sales, which totaled $55.49 million, reflecting strong domestic demand. International revenue also rose 3.9% to reach $21.66 million.
“Kewaunee again delivered another strong quarter, closing out fiscal year 2025 on a high note,” said Thomas D. Hull III, President and CEO. “Our team continues to embrace the momentum we have generated in the market, delivering on our commitments to our customers.”
The company’s order backlog swelled to $214.6 million at the end of the quarter, compared to $155.6 million a year earlier, signaling a strong pipeline heading into the new fiscal year.
For the full fiscal year, Kewaunee posted adjusted EPS of $5.37 and revenue of $240.47 million, marking annual growth of 28.2% and 18%, respectively.
Looking forward, Hull expressed confidence in both organic expansion and strategic growth through acquisitions, highlighting the recent acquisition of Nu Aire, Inc. as a key part of the company’s long-term growth strategy.